Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
The American Journal of Clinical Nutrition
|
October 22, 2014
GLP-1 response to 2 energy-matched snacks
Antonio C Bossi
Diabetes Care
|
August 25, 2016
Comment on Muraki et al. Potato Consumption and Risk of Type 2 Diabetes: Results From Three Prospective Cohort Studies. Diabetes Care 2016;39:376-384
Antonio C Bossi
Diabetes Care
|
September 30, 2008
Bent needles: another problem in glycemic control
Antonio C Bossi, Eunice O Ansah
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
October 14, 2020
A Response To: Sodium-Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions
Antonio C Bossi, Franco Forloni, Paolo L Colombelli
Giornale Italiano Di Cardiologia (2006)
|
July 30, 2014
[The SAVOR-TIMI 53 study]
Andrea Di Lenarda, Riccardo Candido, Giovanni Cioffi, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
September 25, 2020
ANDREW: A Multicenter, Prospective, Observational Study in Patients with Type 2 Diabetes on Persistent Treatment with Dulaglutide
Antonio C Bossi, Valentina De Mori, Cristiana Scaranna, et al.
Human Vaccines & Immunotherapeutics
|
June 11, 2024
COVID-19 vaccines and blood glucose control: Friend or foe?
Walter Vena, Stella Pigni, Nazarena Betella, et al.
Clinical Diabetes and Endocrinology
|
July 14, 2017
Determinants of nurse satisfaction using insulin pen devices with safety needles: an exploratory factor analysis
Giovanni Veronesi, Carmine S Poerio, Alessandra Braus, et al.
European Journal of Pharmacology
|
June 8, 2011
Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patients
Giuseppe Derosa, Pietro Putignano, Antonio C Bossi, et al.
BMJ Open Diabetes Research & Care
|
August 4, 2016
PERS&O (PERsistent Sitagliptin treatment & Outcomes): observational retrospective study on cardiovascular risk evolution in patients with type 2 diabetes on persistent sitagliptin treatment
Giulia Buonaiuto, Valentina De Mori, Alessandra Braus, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
The American Journal of Clinical Nutrition
|
October 22, 2014
GLP-1 response to 2 energy-matched snacks
Antonio C Bossi
Diabetes Care
|
August 25, 2016
Comment on Muraki et al. Potato Consumption and Risk of Type 2 Diabetes: Results From Three Prospective Cohort Studies. Diabetes Care 2016;39:376-384
Antonio C Bossi
Diabetes Care
|
September 30, 2008
Bent needles: another problem in glycemic control
Antonio C Bossi, Eunice O Ansah
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
October 14, 2020
A Response To: Sodium-Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions
Antonio C Bossi, Franco Forloni, Paolo L Colombelli
Giornale Italiano Di Cardiologia (2006)
|
July 30, 2014
[The SAVOR-TIMI 53 study]
Andrea Di Lenarda, Riccardo Candido, Giovanni Cioffi, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
September 25, 2020
ANDREW: A Multicenter, Prospective, Observational Study in Patients with Type 2 Diabetes on Persistent Treatment with Dulaglutide
Antonio C Bossi, Valentina De Mori, Cristiana Scaranna, et al.
Human Vaccines & Immunotherapeutics
|
June 11, 2024
COVID-19 vaccines and blood glucose control: Friend or foe?
Walter Vena, Stella Pigni, Nazarena Betella, et al.
Clinical Diabetes and Endocrinology
|
July 14, 2017
Determinants of nurse satisfaction using insulin pen devices with safety needles: an exploratory factor analysis
Giovanni Veronesi, Carmine S Poerio, Alessandra Braus, et al.
European Journal of Pharmacology
|
June 8, 2011
Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patients
Giuseppe Derosa, Pietro Putignano, Antonio C Bossi, et al.
BMJ Open Diabetes Research & Care
|
August 4, 2016
PERS&O (PERsistent Sitagliptin treatment & Outcomes): observational retrospective study on cardiovascular risk evolution in patients with type 2 diabetes on persistent sitagliptin treatment
Giulia Buonaiuto, Valentina De Mori, Alessandra Braus, et al.
Page
of 2